期刊文献+

RP-HPLC法测定洛索洛芬钠片的含量及有关物质 被引量:5

Determination of Contents and Related Substances in Loxoprofen Sodium Tablets by RP-HPLC
下载PDF
导出
摘要 目的:改进测定洛索洛芬钠片中主成分含量及有关物质的方法。方法:采用反相高效液相色谱法。色谱柱为迪马Inspire C_(18),流动相为乙腈-0.01 mol/L磷酸二氢钾溶液(含0.2%三乙胺,磷酸调节p H至3.0±0.1)(62∶38,V/V),流速为1.0 mL/min,柱温为40℃,检测波长为221 nm,进样量为20μL。结果:洛索洛芬钠峰与相邻杂质峰达到良好分离(分离度>1.5);洛索洛芬钠检测质量浓度线性范围为30.0~90.0μg/mL(r=0.999 8);洛索洛芬钠检测限为0.3μg/mL;精密度、稳定性、重复性试验的RSD<1.0%;回收率为99.00%~99.87%,RSD=0.33%(n=9)。结论:该方法准确、简便、快速,适用于洛索洛芬钠片的质量控制。 OBJECTIVE: To improve the determination method for the contents of main components and related substances in Loxoprofen sodium tablets. METHODS: RP-HPLC method was adopted. The determination was performed on Inspire C18 column with mobile phase consisted of acetonitile-0.01 mol/L potassium dihydrogen phosphate (containing 0.2% triethylamine, phosphoric acid adjusted to 3.0± 0.1,62 : 38, V/V) at the flow rate of 1.0 mL/min. The column temperature was 40℃, and the detection wave- length was set at 221 nm. The sample size was 20 μL. RESULTS: The peak of loxoprofen sodium was well separated with the peak of its related substances (R〉1.5). The linear range of loxoprofen sodium ranged 30.0-90.0 μg/mL (r=0.999 8). The detection lim- it of loxoprofen was 0.3 μg/mL. RSDs of precision, stability and repeatability tests were 〈1.0%. The average recovery rates ranged 99.00%-99.87% (RSD=0.33% ,n=9). CONCLUSIONS: This method is accurate, simple, rapid and suitable for the quali- ty control of Loxoprofen sodium tablets. KEYWORDS RP-HPLC; Loxoprofen sodium tablets; Content; Related substances
出处 《中国药房》 CAS 北大核心 2017年第15期2127-2130,共4页 China Pharmacy
关键词 反相高效液相色谱法 洛索洛芬钠片 含量 有关物质 RP-HPLC Loxoprofen sodium tablets Content Related substances
  • 相关文献

参考文献6

二级参考文献31

  • 1刘宏.乐松口服引起颜面水肿1例[J].解放军保健医学杂志,2004,6(3):145-145. 被引量:1
  • 2韩冬,崔黎丽,李国栋.巴布剂透皮给药基质的研究[J].第二军医大学学报,2005,26(5):572-573. 被引量:44
  • 3杨平,凌云.洛索洛芬引起肾衰一例[J].中华医学杂志,2005,85(31):2229-2229. 被引量:9
  • 4张蓓蓓,张尊建,田媛,汪洋,李先霞.洛索洛芬钠缓释片在比格犬体内的药代动力学[J].中国药科大学学报,2006,37(4):333-336. 被引量:5
  • 5王秀萍,陈斌.洛索洛芬钠缓释片体外释放特性研究[J].医药导报,2007,26(5):490-492. 被引量:7
  • 6[2]The society of Japanese Pharmacopoeia.The Japanese Pharmacopoeia.Thirteenth Edition.Tokyo:YAKUJI NIPPO,Ltd.1996.479-480.
  • 7Brounaugh RL, Maibach HI. Percutaneous absorption: mechanisms-methodology-drug delivery [M]. 2nd ed. New York: Marcel Dekker Inc., 1989: 215-237.
  • 8Simon GA, Maibach HI. The pig as an experimental animal model of percutaneous permeation in man: qualitative and quantitative observations-an overview [J]. Skin Pharmacol Appl Skin Physiol, 2000, 13 (5) : 229-234.
  • 9Kco TS, Kim DH, Ahn SH, a al. Comparison of phannacokinetics of loxoprofen and its active metabolites after an intravenous,intramuscular, and oral administration of loxopmfen in rats: evidence for extrahepatic metabolism[J]. J Pharm Sci, 2005,94(10) :2 187-2 197.
  • 10Kim IW, Chung SJ, Shim CK. Altered metabolism of orally administration of loxoprofen for three consecutive days followed by a sevenday washout[J]. J Pharm Sci, 2002,91(4):973 -979.

共引文献57

同被引文献37

引证文献5

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部